Metformin Shows Potential to Prevent Macular Degeneration
People prescribed the diabetes drug metformin may be less likely to develop age-related macular degeneration.
Stay updated with breaking news from Scan Database. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
People prescribed the diabetes drug metformin may be less likely to develop age-related macular degeneration.
Although oral isotretinoin is an effective treatment for acne, its potential association with psychiatric symptoms has limited its widespread clinical use.
Share this article Share this article INDIANAPOLIS, April 23, 2021 /PRNewswire/ -- Through clinical trial meta-analysis and real-world evidence, Eli Lilly and Company's (NYSE: LLY) Taltz ® (ixekizumab) demonstrated greater success in key measured treatment outcomes compared to other biologics in adults with moderate to severe plaque psoriasis. In the first one-year network meta-analysis based on area under the curve, Taltz showed numerically greater cumulative benefits on completely clear skin over one year compared to seven other biologics, as measured by Psoriasis Area Severity Index (PAS...